ExploreWatchlistsPricing
  1. JP-listed companies
  2. KNC Laboratories Co., Ltd.
  3. Financials
  4. Cash from investing

KNC Laboratories Co., Ltd. (6568)

Market cap
¥9.6B
P/E ratio
12.4x
Develops and manufactures specialized organic chemicals for pharmaceutical, electronics, and biotech companies to accelerate their product development.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2026-2,697-18.82%
Mar 31, 2025-3,323+40.25%
Mar 31, 2024-2,369+106.58%
Mar 31, 2023-1,147+86.93%
Mar 31, 2022-614-7.05%
Mar 31, 2021-660-64.57%
Mar 31, 2020-1,863-11.75%
Mar 31, 2019-2,111+202.78%
Mar 31, 2018-697-1311.31%
Mar 31, 201758

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat